Literature DB >> 20112420

Docking of insulin to a structurally equilibrated insulin receptor ectodomain.

Harish Vashisth1, Cameron F Abrams.   

Abstract

The insulin receptor (IR) is a homo-dimeric, disulfide-linked, membrane-spanning tyrosine kinase. IR displays negative cooperativity in insulin binding to its two pockets, suggesting "see-sawing" between symmetry-inverted conformations. The crystal structure of the dimeric IR ectodomain, IRDeltabeta [PDB code 2DTG (McKern et al., Nature 2006 443:218-221)], provides structural bases for this speculation. Unfortunately, neither binding pocket of the crystallographic IRDeltabeta structure allows steric accommodation of insulin. During almost 70-ns of all-atom, explicit-water MD simulation ( approximately 0.5 million atoms), IRDeltabeta undergoes significant asymmetric interdomain and intersubunit conformational fluctuations that do not alter its quaternary structure. Subtle variations in intersubunit buried surface area coincide with these conformational fluctuations, resulting in one easily-accessible insulin binding pocket with the other blocked. We use a combination of Metropolis Monte-Carlo and MD simulations to dock both T- and R-state insulin into the open binding pocket. Both complexes remain stable during 30-ns of MD simulation. In these complexes, "hexamer interface" residues on insulin directly contact the "site-2" epitope on the first type-III fibronectin domain (F1) of IR. Our results support the hypothesis that intersubunit flexibility of IR, governed by alternating modulation of buried intersubunit surface area, is the physical mechanism underlying a "see-saw" model of negative cooperativity. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20112420     DOI: 10.1002/prot.22670

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  9 in total

1.  Characterization of homodimer interfaces with cross-linking mass spectrometry and isotopically labeled proteins.

Authors:  Diogo B Lima; John T Melchior; Jamie Morris; Valmir C Barbosa; Julia Chamot-Rooke; Mariana Fioramonte; Tatiana A C B Souza; Juliana S G Fischer; Fabio C Gozzo; Paulo C Carvalho; W Sean Davidson
Journal:  Nat Protoc       Date:  2018-02-01       Impact factor: 13.491

2.  Structures and interactions of insulin-like peptides from cone snail venom.

Authors:  Biswajit Gorai; Harish Vashisth
Journal:  Proteins       Date:  2021-10-27

3.  Insulin Dissociates by Diverse Mechanisms of Coupled Unfolding and Unbinding.

Authors:  Adam Antoszewski; Chi-Jui Feng; Bodhi P Vani; Erik H Thiede; Lu Hong; Jonathan Weare; Andrei Tokmakoff; Aaron R Dinner
Journal:  J Phys Chem B       Date:  2020-06-25       Impact factor: 2.991

Review 4.  Theoretical and computational studies of peptides and receptors of the insulin family.

Authors:  Harish Vashisth
Journal:  Membranes (Basel)       Date:  2015-02-11

5.  Molecular Dynamics Simulations of Insulin: Elucidating the Conformational Changes that Enable Its Binding.

Authors:  Anastasios Papaioannou; Serdar Kuyucak; Zdenka Kuncic
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

Review 6.  Progress in Simulation Studies of Insulin Structure and Function.

Authors:  Biswajit Gorai; Harish Vashisth
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

7.  Flexibility in the insulin receptor ectodomain enables docking of insulin in crystallographic conformation observed in a hormone-bound microreceptor.

Authors:  Harish Vashisth
Journal:  Membranes (Basel)       Date:  2014-10-10

8.  All-Atom Structural Models of the Transmembrane Domains of Insulin and Type 1 Insulin-Like Growth Factor Receptors.

Authors:  Hossein Mohammadiarani; Harish Vashisth
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-20       Impact factor: 5.555

9.  Allosteric regulation in CRISPR/Cas1-Cas2 protospacer acquisition mediated by DNA and Cas2.

Authors:  Chunhong Long; Liqiang Dai; Chao E; Lin-Tai Da; Jin Yu
Journal:  Biophys J       Date:  2021-06-29       Impact factor: 3.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.